Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.81 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.67 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.56 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.56 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.53 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.53 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.51 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.51 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3643202 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL12349998 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL17203936 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL9652090 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL8512461 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL12350003 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL3994160 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL15649884 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL15649498 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL11216778 | 1.00 | FAAH (0.81) | FAAHMEN1MAPK1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025043460-A1 | ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS | L'OREAL (FR) | 2025-03-06 | — | — | WO | claimed |
| CN-118222360-A | Fabric cleaning agent and preparation method thereof | 广州花语精细化工有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-114191323-B | Gemini glutamic acid amino acid surfactant composition, and preparation method and application thereof | 岳阳科罗德联合化学工业有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-115427007-A | Transparent shampoo block and preparation method thereof | 汉高股份有限及两合公司 | 2022-12-02 | — | — | CN | claimed |
| CN-110325614-B | Polishing liquid, method for producing polishing liquid, polishing liquid stock solution container, and chemical mechanical polishing method | 富士胶片株式会社 | 2022-06-28 | — | — | CN | claimed |
| CN-109575645-B | Aluminum paste for alcohol-water type ink and preparation method thereof | 长沙族兴新材料股份有限公司 | 2020-12-29 | — | — | CN | claimed |
| CN-111170883-A | Fatty acyl amino acid polyhydroxy ester compound and preparation method thereof | 岳阳科罗德联合化学工业有限公司 | 2020-05-19 | — | — | CN | claimed |
| CN-109575645-A | A kind of aluminum paste and preparation method thereof for alcohol water type ink | 长沙族兴新材料股份有限公司 | 2019-04-05 | — | — | CN | claimed |
| CN-108795592-A | A kind of aqua type industrial cleaning agent and preparation method thereof | 长沙普济生物科技股份有限公司 | 2018-11-13 | — | — | CN | claimed |
| CN-106726670-A | A kind of skin protection cosmetics comprising N acyl aminos hydrochlorate/plant peptide combinations and preparation method thereof | 长沙普济生物科技股份有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106491380-A | Special N acylamino acids anion surfactant type mildy wash/cream of a kind of face cleaning instrument and preparation method thereof | 长沙普济生物科技股份有限公司 | 2017-03-15 | — | — | CN | claimed |
| CN-106473943-A | A kind of anion surfactant of acylamino acid containing N and children's shower cream and the preparation method of antibacterial peptide combinations | 长沙普济生物科技股份有限公司 | 2017-03-08 | — | — | CN | claimed |
| CN-106398905-A | Application of hydroxyl substituent of 2-amino-2-methyl propane in amino acid transparent soap | 佛山市芊茹化妆品有限公司 | 2017-02-15 | — | — | CN | claimed |
| CN-103479529-A | Surfactant composition and uses thereof | SUZHOU YUANSUJI CHEMICAL INDUSTRY CO LTD | 2014-01-01 | — | — | CN | claimed |
| CN-103479532-A | Surfactant composition and uses thereof | SUZHOU YUANSUJI CHEMICAL INDUSTRY CO LTD | 2014-01-01 | — | — | CN | claimed |
| US-20060073177-A1 | Gel composition | AJINOMOTO CO. INC (JP) | 2006-04-06 | — | — | US | claimed |
| EP-1609836-A1 | GEL-STATE COMPOSITION | Ajinomoto Co., Inc. (JP) | 2005-12-28 | — | — | EP | claimed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | claimed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | claimed |
| CN-122055379-A | Compounds containing one or more diboronate esters and related insulin analogues | 普罗托莫科技公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12558296-B2 | Oil-in-water emulsion gel composition | L V M H RECHERCHE (FR) | 2026-02-24 | — | — | US | disclosed |
| US-20260035371-A1 | COMPOUNDS USEFUL IN HIV THERAPY | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2026-02-05 | — | — | US | disclosed |
| EP-4662197-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2025-12-17 | — | — | EP | disclosed |
| WO-2025133664-A1 | OIL-IN-WATER EMULSION | L V M H RECHERCHE (FR) | 2025-06-26 | — | — | WO | disclosed |
| CN-120051267-A | Solid surfactant composition | 蓝宝迪有限公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-119677541-A | Aromatic boron-containing compounds and related insulin analogues | 原聚体科技公司 | 2025-03-21 | — | — | CN | disclosed |
| WO-2025043460-A1 | ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS | L'OREAL (FR) | 2025-03-06 | — | — | WO | disclosed |
| US-12240853-B2 | Compounds useful in HIV therapy | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2025-03-04 | — | — | US | disclosed |
| US-20240425630-A1 | POLYMER DISPERSION COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-12-26 | — | — | US | disclosed |
| CN-115916887-B | Amphiphilic alginic acid particle group and method for producing the same | 日清纺控股株式会社 | 2024-12-03 | — | — | CN | disclosed |
| EP-4448590-A1 | POLYMER DISPERSION COMPOSITION | Dow Global Technologies LLC (US) | 2024-10-23 | — | — | EP | disclosed |
| WO-2024165426-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2024-08-15 | — | — | WO | disclosed |
| EP-4414360-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2024-08-14 | — | — | EP | disclosed |
| CN-118382649-A | Polymer dispersion composition | 陶氏环球技术有限责任公司 | 2024-07-23 | — | — | CN | disclosed |
| WO-2024142846-A1 | COSMETIC COMPOSITION | 株式会社 資生堂 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024142843-A1 | COSMETIC COMPOSITION | 株式会社 資生堂 | 2024-07-04 | — | — | WO | disclosed |
| CN-118284398-A | Cleaning agent composition | 味之素株式会社 | 2024-07-02 | — | — | CN | disclosed |
| CN-118222360-A | Fabric cleaning agent and preparation method thereof | 广州花语精细化工有限公司 | 2024-06-21 | — | — | CN | disclosed |
| US-20240182473-A1 | COMPOUNDS USEFUL IN HIV THERAPY | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2024-06-06 | — | — | US | disclosed |
| US-20230374045-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND RELATED INSULIN ANALOGS | PROTOMER TECHNOLOGIES INC. | 2023-11-23 | — | — | US | disclosed |
| WO-2023225534-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND RELATED INSULIN ANALOGS | PROTOMER TECHNOLOGIES INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| CN-116917297-A | Aromatic boron-containing compounds and insulin analogues | 原聚体科技公司 | 2023-10-20 | — | — | CN | disclosed |
| EP-4247429-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND INSULIN ANALOGS | Protomer Technologies Inc. (US) | 2023-09-27 | — | — | EP | disclosed |
| CN-116685305-A | Cleaning composition | 日本乐敦制药株式会社 | 2023-09-01 | — | — | CN | disclosed |
| CN-116621186-A | Vermicular nano silicon dioxide and preparation method thereof | 河南大学 | 2023-08-22 | — | — | CN | disclosed |
| EP-3470505-B1 | CLEANING COMPOSITION | SHINETSU CHEMICAL CO (JP) | 2023-08-02 | — | — | EP | disclosed |
| CN-116472025-A | Blends of N-acyl alanine salts and other N-acyl amino acid surfactants and derivatives thereof | 宝洁公司 | 2023-07-21 | — | — | CN | disclosed |
| WO-2023114625-A1 | POLYMER DISPERSION COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-22 | — | — | WO | disclosed |
| US-20230174534-A1 | COMPOUNDS USEFUL IN HIV THERAPY | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2023-06-08 | — | — | US | disclosed |
| US-20230174534-A1 | COMPOUNDS USEFUL IN HIV THERAPY | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2023-06-08 | — | — | US | disclosed |
| US-20230174534-A1 | COMPOUNDS USEFUL IN HIV THERAPY | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2023-06-08 | — | — | US | disclosed |
| WO-2023090455-A1 | DETERGENT COMPOSITION | 味の素株式会社 | 2023-05-25 | — | — | WO | disclosed |
| US-20230134116-A1 | CONJUGATES FOR SELECTIVE RESPONSIVENESS TO VICINAL DIOLS | PROTOMER TECHNOLOGIES, INC. | 2023-05-04 | — | — | US | disclosed |
| CN-115843257-A | Conjugates for selective responsiveness to vicinal diols | 原聚体科技公司 | 2023-03-24 | — | — | CN | disclosed |
| EP-4126058-A1 | CONJUGATES FOR SELECTIVE RESPONSIVENESS TO VICINAL DIOLS | Protomer Technologies Inc. (US) | 2023-02-08 | — | — | EP | disclosed |
| US-20220411425-A1 | COMPOUNDS USEFUL IN HIV THERAPY | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2022-12-29 | — | — | US | disclosed |
| US-20220411425-A1 | COMPOUNDS USEFUL IN HIV THERAPY | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2022-12-29 | — | — | US | disclosed |
| CN-115427007-A | Transparent shampoo block and preparation method thereof | 汉高股份有限及两合公司 | 2022-12-02 | — | — | CN | disclosed |
| US-20220347063-A1 | OIL-IN-WATER EMULSION GEL COMPOSITION | L V M H RECHERCHE (FR) | 2022-11-03 | — | — | US | disclosed |
| CN-110022845-B | Foamable compositions | 莱雅公司 | 2022-10-04 | — | — | CN | disclosed |
| WO-2022202766-A1 | CLEANING COMPOSITION | ロート製薬株式会社 | 2022-09-29 | — | — | WO | disclosed |
| WO-2022168894-A1 | CLOTH OR PAPER ANTI-POLLUTION MATERIAL | 日産化学株式会社 | 2022-08-11 | — | — | WO | disclosed |
| CN-110325614-B | Polishing liquid, method for producing polishing liquid, polishing liquid stock solution container, and chemical mechanical polishing method | 富士胶片株式会社 | 2022-06-28 | — | — | CN | disclosed |
| WO-2022109078-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND INSULIN ANALOGS | PROTOMER TECHNOLOGIES INC. (US) | 2022-05-27 | — | — | WO | disclosed |
| EP-3989916-A1 | OIL-IN- WATER EMULSION GEL COMPOSITION | L V M H RECHERCHE (FR) | 2022-05-04 | — | — | EP | disclosed |
| US-11298301-B2 | Oil-in-water emulsified cosmetic | LVMH RECHERCHE (FR) | 2022-04-12 | — | — | US | disclosed |
| EP-3727279-B1 | OIL-IN-WATER EMULSIFIED COSMETIC | LVMH RECH (FR) | 2022-01-26 | — | — | EP | disclosed |
| EP-3934760-A1 | COMPOUNDS USEFUL IN HIV THERAPY | GlaxoSmithKline Intellectual Property (No.2) Limited (GB) | 2022-01-12 | — | — | EP | disclosed |
| CN-113811360-A | Compounds for HIV treatment | 葛兰素史密斯克莱知识产权（第2 号）有限公司 | 2021-12-17 | — | — | CN | disclosed |
| US-20210369815-A1 | GLUCOSE RESPONSIVE INSULINS | PROTOMER TECHNOLOGIES, INC. | 2021-12-02 | — | — | US | disclosed |
| US-11179307-B2 | Foamable composition | L'OREAL (FR) | 2021-11-23 | — | — | US | disclosed |
| WO-2021202802-A1 | CONJUGATES FOR SELECTIVE RESPONSIVENESS TO VICINAL DIOLS | PROTOMER TECHNOLOGIES INC. (US) | 2021-10-07 | — | — | WO | disclosed |
| US-11052133-B2 | Glucose responsive insulins | PROTOMER TECHNOLOGIES, INC. (US) | 2021-07-06 | — | — | US | disclosed |
| CN-108840345-B | Chiral ultra-microporous silicon dioxide and preparation method thereof | 江西农业大学 | 2021-04-27 | — | — | CN | disclosed |
| WO-2021048577-A1 | OIL-IN- WATER EMULSION GEL COMPOSITION | L V M H RECHERCHE (FR) | 2021-03-18 | — | — | WO | disclosed |
| CN-109575645-B | Aluminum paste for alcohol-water type ink and preparation method thereof | 长沙族兴新材料股份有限公司 | 2020-12-29 | — | — | CN | disclosed |
| EP-3727279-A1 | OIL-IN-WATER EMULSIFIED COSMETIC | LVMH Recherche (FR) | 2020-10-28 | — | — | EP | disclosed |
| US-10736826-B2 | Cream-like composition | AJINOMOTO CO., INC. (JP) | 2020-08-11 | — | — | US | disclosed |
| US-20200197264-A1 | OIL-IN-WATER EMULSIFIED COSMETIC | LVMH RECHERCHE (FR) | 2020-06-25 | — | — | US | disclosed |
| US-10688024-B2 | Cleaning composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-06-23 | — | — | US | disclosed |
| CN-111170883-A | Fatty acyl amino acid polyhydroxy ester compound and preparation method thereof | 岳阳科罗德联合化学工业有限公司 | 2020-05-19 | — | — | CN | disclosed |
| EP-3648769-A1 | HUMAN MICROBIOTA DERIVED N-ACYL AMIDES FOR THE TREATMENT OF HUMAN DISEASE | The Rockefeller University (US) | 2020-05-13 | — | — | EP | disclosed |
| US-20200113950-A1 | Human microbiota derived N-acyl amides for the treatment of human disease | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-04-16 | — | — | US | disclosed |
| US-20200078283-A1 | FOAMABLE COMPOSITION | L'OREAL (FR) | 2020-03-12 | — | — | US | disclosed |
| WO-2019232629-A1 | PRODUCTS AND METHODS FOR THE TREATMENT OF MIXTURES OF WATER AND HYDROPHOBIC LIQUIDS | B.C. RESEARCH INC. (CA) | 2019-12-12 | — | — | WO | disclosed |
| EP-3554468-A1 | FOAMABLE COMPOSITION | L'Oréal (FR) | 2019-10-23 | — | — | EP | disclosed |
| US-20190247468-A1 | GLUCOSE RESPONSIVE INSULINS | PROTOMER TECHNOLOGIES, INC. | 2019-08-15 | — | — | US | disclosed |
| CN-110022845-A | Foamable composite | 莱雅公司 | 2019-07-16 | — | — | CN | disclosed |
| US-20190133897-A1 | CREAM-LIKE COMPOSITION | AJINOMOTO CO., INC. (JP) | 2019-05-09 | — | — | US | disclosed |
| CN-106596768-B | The remaining liquid phase detection method of fatty acid in amino acid surfactant | 广州天赐高新材料股份有限公司 | 2019-04-30 | — | — | CN | disclosed |
| CN-109652216-A | Cleaning compositions | 信越化学工业株式会社 | 2019-04-19 | — | — | CN | disclosed |
| EP-3470505-A1 | CLEANING COMPOSITION | Shin-Etsu Chemical Co., Ltd. (JP) | 2019-04-17 | — | — | EP | disclosed |
| US-20190105241-A1 | CLEANING COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-04-11 | — | — | US | disclosed |
| CN-109575645-A | A kind of aluminum paste and preparation method thereof for alcohol water type ink | 长沙族兴新材料股份有限公司 | 2019-04-05 | — | — | CN | disclosed |
| WO-2019006246-A1 | HUMAN MICROBIOTA DERIVED N-ACYL AMIDES FOR THE TREATMENT OF HUMAN DISEASE | THE ROCKEFELLER UNIVERSITY (US) | 2019-01-03 | — | — | WO | disclosed |
| CN-108840345-A | A kind of chirality super-microporous silicon dioxide and preparation method thereof | 江西农业大学 | 2018-11-20 | — | — | CN | disclosed |
| CN-108795592-A | A kind of aqua type industrial cleaning agent and preparation method thereof | 长沙普济生物科技股份有限公司 | 2018-11-13 | — | — | CN | disclosed |
| WO-2018110311-A1 | FOAMABLE COMPOSITION | L'OREAL (FR) | 2018-06-21 | — | — | WO | disclosed |
| EP-3291828-A1 | GLUCOSE RESPONSIVE INSULINS | Mahdavi, Alborz (US) | 2018-03-14 | — | — | EP | disclosed |
| CN-106442829-B | It is a kind of while detect the method for aliphatic acid and active matter content in fatty acyl neutral amino acid surfactant | 广州天赐高新材料股份有限公司 | 2018-01-02 | — | — | CN | disclosed |
| US-20170304177-A1 | USE OF ISOSORBIDE ESTER AND N-ACYLATED AMINO ACID DERIVATIVES AS ANTI-AGEING AGENT FOR THE HUMAN SKIN | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2017-10-26 | — | — | US | disclosed |
| EP-3209277-A1 | USE OF ISOSORBIDE ESTER AND N-ACYLATED AMINO ACID DERIVATIVES AS ANTI-AGEING AGENT FOR THE HUMAN SKIN | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2017-08-30 | — | — | EP | disclosed |
| US-9745355-B2 | Binding-site modified lectins and uses thereof | SMARTCELLS, INC. (US) | 2017-08-29 | — | — | US | disclosed |
| CN-106726670-A | A kind of skin protection cosmetics comprising N acyl aminos hydrochlorate/plant peptide combinations and preparation method thereof | 长沙普济生物科技股份有限公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-106596768-A | Liquid phase detection method for fatty acid residue in amino acid surfactant | 广州天赐高新材料股份有限公司 | 2017-04-26 | — | — | CN | disclosed |
| CN-106596767-A | Method for quick determination of fatty acid residues in amino acid surfactants | 广州天赐高新材料股份有限公司 | 2017-04-26 | — | — | CN | disclosed |
| CN-106491380-A | Special N acylamino acids anion surfactant type mildy wash/cream of a kind of face cleaning instrument and preparation method thereof | 长沙普济生物科技股份有限公司 | 2017-03-15 | — | — | CN | disclosed |
| CN-106473943-A | A kind of anion surfactant of acylamino acid containing N and children's shower cream and the preparation method of antibacterial peptide combinations | 长沙普济生物科技股份有限公司 | 2017-03-08 | — | — | CN | disclosed |
| CN-106442829-A | Method of simultaneously detecting contents of fatty acid and active matter in fatty acyl neutral amino acid surfactant | 广州天赐高新材料股份有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-106398905-A | Application of hydroxyl substituent of 2-amino-2-methyl propane in amino acid transparent soap | 佛山市芊茹化妆品有限公司 | 2017-02-15 | — | — | CN | disclosed |
| US-20170022262-A1 | CRYSTALLINE INSULIN-CONJUGATES | SMARTCELLS, INC. (US) | 2017-01-26 | — | — | US | disclosed |
| EP-2178492-B1 | HAIR TREATMENT AGENT COMPRISING AN ACYLAMINO ACID DERIVATIVE, A HYDROXYALKYLAMINE, AND 2-(2-HYDROXYETHYL)-P-PHENYLENEDIAMINE | HENKEL AG & CO KGAA (DE) | 2016-12-14 | — | — | EP | disclosed |
| WO-2016179568-A1 | GLUCOSE RESPONSIVE INSULINS | PROTOMER TECHNOLOGIES, INC. (US) | 2016-11-10 | — | — | WO | disclosed |
| US-9265838-B2 | Conjugate based systems for controlled drug delivery | SMART CELLS, INC. (US) | 2016-02-23 | — | — | US | disclosed |
| EP-2925345-A1 | O-GLYCOSYLATED CARBOXY TERMINAL PORTION (CTP) PEPTIDE-BASED INSULIN AND INSULIN ANALOGUES | Merck Sharp & Dohme Corp. (US) | 2015-10-07 | — | — | EP | disclosed |
| US-20150250882-A1 | Fatty Acid Acylated Amino Acids for Growth Hormone Delivery | NOVO NORDISK HEALTHCARE AG (CH) | 2015-09-10 | — | — | US | disclosed |
| EP-2908845-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR GROWTH HORMONE DELIVERY | Novo Nordisk Health Care AG (CH) | 2015-08-26 | — | — | EP | disclosed |
| US-20140342980-A1 | BINDING-SITE MODIFIED LECTINS AND USES THEREOF | SMARTCELLS INC (US) | 2014-11-20 | — | — | US | disclosed |
| US-20140274888-A1 | CONJUGATE BASED SYSTEMS FOR CONTROLLED DRUG DELIVERY | SMARTCELLS, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-8778363-B2 | Oil-in-water emulsion skin care cosmetic composition | SHISEIDO COMPANY, LTD. (JP) | 2014-07-15 | — | — | US | disclosed |
| WO-2014088836-A1 | O-GLYCOSYLATED CARBOXY TERMINAL PORTION (CTP) PEPTIDE-BASED INSULIN AND INSULIN ANALOGUES | MERCK SHARP & DOHME CORP. (US) | 2014-06-12 | — | — | WO | disclosed |
| WO-2014060512-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR GROWTH HORMONE DELIVERY | NOVO NORDISK HEALTH CARE AG (CH) | 2014-04-24 | — | — | WO | disclosed |
| CN-103479532-A | Surfactant composition and uses thereof | SUZHOU YUANSUJI CHEMICAL INDUSTRY CO LTD | 2014-01-01 | — | — | CN | disclosed |
| CN-103479529-A | Surfactant composition and uses thereof | SUZHOU YUANSUJI CHEMICAL INDUSTRY CO LTD | 2014-01-01 | — | — | CN | disclosed |
| CN-102448426-B | Oil-in-water emulsion cosmetic preparation for skin care | SHISEDO CO LTD | 2013-11-06 | — | — | CN | disclosed |
| EP-2598170-A2 | DRUG-LIGAND CONJUGATES, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO | Smartcells, Inc. (US) | 2013-06-05 | — | — | EP | disclosed |
| EP-2598527-A2 | RECOMBINANTLY EXPRESSED INSULIN POLYPEPTIDES AND USES THEREOF | Smartcells, Inc. (US) | 2013-06-05 | — | — | EP | disclosed |
| EP-2598522-A2 | RECOMBINANT LECTINS, BINDING-SITE MODIFIED LECTINS AND USES THEREOF | Smartcells, Inc. (US) | 2013-06-05 | — | — | EP | disclosed |
| EP-2598171-A2 | DRUG-LIGAND CONJUGATES, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO | Smartcells, Inc. (US) | 2013-06-05 | — | — | EP | disclosed |
| US-8431619-B2 | Aqueous composition for cosmetics and cosmetic including the same | AKZO NOBEL N.V. (NL) | 2013-04-30 | — | — | US | disclosed |
| US-8362089-B2 | Producing stable, controlled viscosity, wide pH range of use and thixotropic products; combining crosslinked product of hydroxyalkyl modified starch and water soluble polymer | AKZO NOBEL N.V. (NL) | 2013-01-29 | — | — | US | disclosed |
| US-20120237462-A1 | Aqueous Composition For Cosmetics And Cosmetic Including the Same | AKZO NOBEL N.V. (NL) | 2012-09-20 | — | — | US | disclosed |
| WO-2012114051-A1 | CUTANEOUS PHARMACEUTICAL COMPOSITIONS FOR THE LOCAL TREATMENT OF CANINE ATOPIC DERMATITIS | PHYSICA PHARMA SAS (FR) | 2012-08-30 | — | — | WO | disclosed |
| WO-2012114054-A1 | LOCALLY ACTING PHARMACEUTICAL COMPOSITIONS WHICH CAN BE ADMINISTERED BY CUTANEOUS APPLICATION | PHYSICA PHARMA SAS (FR) | 2012-08-30 | — | — | WO | disclosed |
| US-20120172433-A1 | Oil-In-Water Emulsion Skin Care Cosmetic Composition | SHISEIDO COMPANY, LTD. (JP) | 2012-07-05 | — | — | US | disclosed |
| CN-102448426-A | Oil-in-water emulsion skin cosmetic | SHISEIDO CO LTD | 2012-05-09 | — | — | CN | disclosed |
| US-20120046223-A1 | EXOGENOUSLY TRIGGERED CONTROLLED RELEASE MATERIALS AND USES THEREOF | SMARTCELLS, INC. | 2012-02-23 | — | — | US | disclosed |
| WO-2012015687-A2 | DRUG-LIGAND CONJUGATES, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO | SMARTCELLS, INC. (US) | 2012-02-02 | — | — | WO | disclosed |
| WO-2012015681-A2 | DRUG-LIGAND CONJUGATES, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO | SMARTCELLS, INC. (US) | 2012-02-02 | — | — | WO | disclosed |
| WO-2012015691-A2 | RECOMBINANT LECTINS, BINDING-SITE MODIFIED LECTINS AND USES THEREOF | SMARTCELLS, INC. (US) | 2012-02-02 | — | — | WO | disclosed |
| WO-2012015692-A2 | RECOMBINANTLY EXPRESSED INSULIN POLYPEPTIDES AND USES THEREOF | SMARTCELLS, INC. (US) | 2012-02-02 | — | — | WO | disclosed |
| EP-2408808-A1 | TERMINALLY-FUNCTIONALIZED CONJUGATES AND USES THEREOF | Smartcells, Inc. (US) | 2012-01-25 | — | — | EP | disclosed |
| EP-2408470-A1 | Soluble non-depot insulin conjugates and uses thereof | Smartcells, Inc. (US) | 2012-01-25 | — | — | EP | disclosed |
| US-20120014908-A1 | TERMINALLY-FUNCTIONALIZED CONJUGATES AND USES THEREOF | SMARTCELLS, INC. | 2012-01-19 | — | — | US | disclosed |
| US-20120010134-A1 | SOLUBLE NON-DEPOT INSULIN CONJUGATES AND USES THEREOF | SMARTCELLS, INC. | 2012-01-12 | — | — | US | disclosed |
| EP-2391646-A1 | CRYSTALLINE INSULIN-CONJUGATES | Smartcells, Inc. (US) | 2011-12-07 | — | — | EP | disclosed |
| US-20110281792-A1 | BINDING-SITE MODIFIED LECTINS AND USES THEREOF | SMARTCELLS, INC. | 2011-11-17 | — | — | US | disclosed |
| US-20110281939-A1 | POLYNUCLEOTIDE APTAMER-BASED CROSS-LINKED MATERIALS AND USES THEREOF | SMARTCELLS, INC. | 2011-11-17 | — | — | US | disclosed |
| US-20110281791-A1 | CRYSTALLINE INSULIN-CONJUGATES | SMARTCELLS, INC. | 2011-11-17 | — | — | US | disclosed |
| US-20110275560-A1 | SYNTHETIC CONJUGATES AND USES THEREOF | SMARTCELLS, INC. | 2011-11-10 | — | — | US | disclosed |
| CN-1860371-B | Protein kinase C zeta as a drug target for arthritis and other inflammatory diseases | WYETH CORP | 2010-11-24 | — | — | CN | disclosed |
| WO-2010088300-A1 | CRYSTALLINE INSULIN-CONJUGATES | SMARTCELLS, INC. (US) | 2010-08-05 | — | — | WO | disclosed |
| EP-1314717-B1 | Method for preparing N-long chain acyl neutral amino acid | AJINOMOTO KK (JP) | 2010-04-28 | — | — | EP | disclosed |
| EP-2178492-A1 | HAIR TREATMENT AGENT COMPRISING AN ACYLAMINO ACID DERIVATIVE, A HYDROXYALKYLAMINE, AND 2-(2-HYDROXYETHYL)-P-PHENYLENEDIAMINE | Henkel AG & Co. KGaA (DE) | 2010-04-28 | — | — | EP | disclosed |
| CN-101528248-A | Antimicrobial peptides | AUSTRIA WIRTSCHAFTSSERV GMBH (AT) | 2009-09-09 | — | — | CN | disclosed |
| EP-1586625-B1 | NOVEL SURFACTANTS AND USE THEREOF | P & PF CO LTD (JP) | 2009-06-03 | — | — | EP | disclosed |
| EP-0872481-B1 | DEPSIPEPTIDE DERIVATIVE, PROCESS FOR PRODUCTION THEREOF, AND NOVEL INTERMEDIATE THEREFOR | ASTELLAS PHARMA INC (JP) | 2009-03-18 | — | — | EP | disclosed |
| EP-1044676-B1 | Oily material composition | AJINOMOTO KK (JP) | 2009-03-18 | — | — | EP | disclosed |
| WO-2009024362-A1 | HAIR TREATMENT AGENT COMPRISING AN ACYLAMINO ACID DERIVATIVE, A HYDROXYALKYLAMINE, AND 2-(2-HYDROXYETHYL)-P-PHENYLENEDIAMINE | HENKEL AG & CO. KGAA (DE) | 2009-02-26 | — | — | WO | disclosed |
| US-20080131469-A1 | Aqueous composition for cosmetics and cosmetic including the same | NATIONAL STARCH AND CHEMICAL INVERSTMENT HOLDING CORPORATION (US) | 2008-06-05 | — | — | US | disclosed |
| EP-1486514-B1 | Acrylic polymer composition for cosmetics | NAT STARCH CHEM INVEST (US) | 2008-01-16 | — | — | EP | disclosed |
| CN-1860371-A | Protein kinase C zeta as a drug target for arthritis and other inflammatory diseases | WYETH CORP (US) | 2006-11-08 | — | — | CN | disclosed |
| US-20060073177-A1 | Gel composition | AJINOMOTO CO. INC (JP) | 2006-04-06 | — | — | US | disclosed |
| US-20060062751-A1 | Novel surfactants and use thereof | P & PF CO., LTD. (JP) | 2006-03-23 | — | — | US | disclosed |
| EP-1609836-A1 | GEL-STATE COMPOSITION | Ajinomoto Co., Inc. (JP) | 2005-12-28 | — | — | EP | disclosed |
| EP-1586625-A1 | NOVEL SURFACTANTS AND USE THEREOF | P & PF Co., Ltd. (JP) | 2005-10-19 | — | — | EP | disclosed |
| EP-1486514-A1 | Acrylic polymer composition for cosmetics | National Starch and Chemical Investment Holding Corporation (US) | 2004-12-15 | — | — | EP | disclosed |
| US-20040234486-A1 | Aqueous composition for cosmetics and cosmetic including the same | AKZO NOBEL N.V. (NL) | 2004-11-25 | — | — | US | disclosed |
| US-20040077518-A1 | Granular surfactant and process for producing the same | AJINOMOTO CO., INC. (JP) | 2004-04-22 | — | — | US | disclosed |
| US-6703517-B2 | PURIFIED N-LONG CHAIN ACYL NEUTRAL AMINO ACID FOR USE OF A DETERGENT AND THE LIKE IN A SIMPLE AND CONVENIENT MANNER AND IN A HIGH YIELD BY REACTING A NEUTRAL AMINO ACID SUCH AS GLYCINE, GAMMA -AMINOBUTYRIC ACID, AND ALANINE, WITH A | AJINOMOTO CO., INC. (JP) | 2004-03-09 | — | — | US | disclosed |
| EP-1340806-A1 | GRANULAR SURFACTANT AND PROCESS FOR PRODUCING THE SAME | Ajinomoto Co., Inc. (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-20030125227-A1 | Method for preparing N-long chain acyl neutral amino acid | AJINOMOTO CO. INC. (JP) | 2003-07-03 | — | — | US | disclosed |
| EP-1314717-A1 | Method for preparing N-long chain acyl neutral amino acid | Ajinomoto Co., Inc. (JP) | 2003-05-28 | — | — | EP | disclosed |
| US-6447790-B1 | OXO AMIDES, HAVING GOOD MOISTURE PERMEABILITY AND BARRIER, EMULSIFIER STABILITY AND FEEL, USED AS COSMETIC LOTIONS | AJINOMOTO CO., INC. (JP) | 2002-09-10 | — | — | US | disclosed |
| EP-1044676-A2 | Oily material composition | Ajinomoto Co., Inc. (JP) | 2000-10-18 | — | — | EP | disclosed |
| EP-0648833-B1 | DETERGENT COMPOSITION | AJINOMOTO KK (JP) | 1999-12-29 | — | — | EP | disclosed |
| US-5856436-A | Depsipeptide derivative, process for production thereof, and novel intermediate therefor | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-01-05 | — | — | US | disclosed |
| EP-0872481-A1 | DEPSIPEPTIDE DERIVATIVE, PROCESS FOR PRODUCTION THEREOF, AND NOVEL INTERMEDIATE THEREFOR | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-21 | — | — | EP | disclosed |
| US-5814437-A | LIGHT SENSITIVE ELEMENTS FOR PHOTOGRAPHIC FILMS WITH AUTOMATIC PROCESSING | KONICA CORPORATION (JP) | 1998-09-29 | — | — | US | disclosed |
| US-5689751-A | Automatic processor for silver halide photographic light-sensitive material | KONICA CORPORATION (JP) | 1997-11-18 | — | — | US | disclosed |
| US-5556736-A | PHENYLENEDIAMINE DEVELOPER, REPLENISHING WITH WATER | KONICA CORPORATION (JP) | 1996-09-17 | — | — | US | disclosed |
| US-5529712-A | CONTAINING N-ACYL AMINO ACID SALT OF GLYCINE, ALANINE OR BETA-ALANINE, HIGHER FATTY ACID SALT IN SPECIFIED WEIGHT RATIO | AJINOMOTO CO., INC. (JP) | 1996-06-25 | — | — | US | disclosed |
| EP-0648833-A1 | DETERGENT COMPOSITION | Ajinomoto Co., Inc. (JP) | 1995-04-19 | — | — | EP | disclosed |
| EP-0611986-A1 | Solid photographic processing composition for silver halide color photographic light-sensitive material | KONICA CORPORATION (JP) | 1994-08-24 | — | — | EP | disclosed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | disclosed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | disclosed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (27 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275560-A1 | SYNTHETIC CONJUGATES AND USES THEREOF | SLC2A4, SLC2A8, CD44 | FAAH 4753/4885MEN1 2492/4885MAPK1 3352/4885 |
| US-11052133-B2 | Glucose responsive insulins | GLP1R, GPR119, IAPP | FAAH 4477/4885MEN1 499/4885MAPK1 1261/4885 |
| US-20190247468-A1 | GLUCOSE RESPONSIVE INSULINS | GLP1R, GPR119, IAPP | FAAH 4477/4885MEN1 499/4885MAPK1 1261/4885 |
| US-11179307-B2 | Foamable composition | ANXA11, GRN, ANXA1 | FAAH 194/4885MEN1 2425/4885MAPK1 3596/4885 |
| US-12558296-B2 | Oil-in-water emulsion gel composition | ACR, PLIN3, ATM | FAAH 1198/4885MEN1 1677/4885MAPK1 2838/4885 |
| US-20230174534-A1 | COMPOUNDS USEFUL IN HIV THERAPY | CCR5, CD4, LSS | FAAH 3659/4885MEN1 4018/4885MAPK1 4402/4885 |
| US-20120010134-A1 | SOLUBLE NON-DEPOT INSULIN CONJUGATES AND USES THEREOF | GPR119, IAPP, IRS1 | FAAH 4516/4885MEN1 1045/4885MAPK1 1728/4885 |
| US-20260035371-A1 | COMPOUNDS USEFUL IN HIV THERAPY | CCR5, CCR1, CYC1 | FAAH 2239/4885MEN1 2575/4885MAPK1 3179/4885 |
| US-20140274888-A1 | CONJUGATE BASED SYSTEMS FOR CONTROLLED DRUG DELIVERY | SI, CSGALNACT1, CD44 | FAAH 3119/4885MEN1 1908/4885MAPK1 4735/4885 |
| US-20240182473-A1 | COMPOUNDS USEFUL IN HIV THERAPY | CD4, CCR5, G6PD | FAAH 3802/4885MEN1 4087/4885MAPK1 4011/4885 |
| US-20170304177-A1 | USE OF ISOSORBIDE ESTER AND N-ACYLATED AMINO ACID DERIVATIVES AS ANTI-AGEING AGENT FOR THE HUMAN SKIN | ARG2, ARGLU1, ASS1 | FAAH 410/4885MEN1 4292/4885MAPK1 2483/4885 |
| US-20140342980-A1 | BINDING-SITE MODIFIED LECTINS AND USES THEREOF | SIGLEC7, SIGLEC9, LGALS3BP | FAAH 4681/4885MEN1 3049/4885MAPK1 3742/4885 |
| US-20110281791-A1 | CRYSTALLINE INSULIN-CONJUGATES | IAPP, INSR, GPR119 | FAAH 3984/4885MEN1 208/4885MAPK1 4024/4885 |
| US-20200113950-A1 | Human microbiota derived N-acyl amides for the treatment of human disease | GPR88, GPR18, GPR3 | FAAH 66/4885MEN1 4096/4885MAPK1 3134/4885 |
| US-20110281792-A1 | BINDING-SITE MODIFIED LECTINS AND USES THEREOF | SIGLEC7, SIGLEC9, LGALS3BP | FAAH 4681/4885MEN1 3049/4885MAPK1 3742/4885 |
| US-20230134116-A1 | CONJUGATES FOR SELECTIVE RESPONSIVENESS TO VICINAL DIOLS | GPR119, GLP1R, IAPP | FAAH 946/4885MEN1 609/4885MAPK1 719/4885 |
| US-20060073177-A1 | Gel composition | BCAT1, BCAT2, CUTA | FAAH 204/4885MEN1 2288/4885MAPK1 2682/4885 |
| US-20110281939-A1 | POLYNUCLEOTIDE APTAMER-BASED CROSS-LINKED MATERIALS AND USES THEREOF | PNKP, ADAR, NCL | FAAH 4658/4885MEN1 4273/4885MAPK1 3759/4885 |
| US-20210369815-A1 | GLUCOSE RESPONSIVE INSULINS | GLP1R, GPR119, IAPP | FAAH 4477/4885MEN1 499/4885MAPK1 1261/4885 |
| US-20200078283-A1 | FOAMABLE COMPOSITION | ANXA11, GRN, ANXA1 | FAAH 194/4885MEN1 2425/4885MAPK1 3596/4885 |
| US-20170022262-A1 | CRYSTALLINE INSULIN-CONJUGATES | IAPP, INSR, GPR119 | FAAH 3984/4885MEN1 208/4885MAPK1 4024/4885 |
| US-20120046223-A1 | EXOGENOUSLY TRIGGERED CONTROLLED RELEASE MATERIALS AND USES THEREOF | CD63, NSF, MSN | FAAH 3447/4885MEN1 2408/4885MAPK1 4822/4885 |
| US-20120014908-A1 | TERMINALLY-FUNCTIONALIZED CONJUGATES AND USES THEREOF | NPY1R, NTSR1, GRPR | FAAH 2803/4885MEN1 600/4885MAPK1 3295/4885 |
| US-12240853-B2 | Compounds useful in HIV therapy | CCR5, CD4, LSS | FAAH 3659/4885MEN1 4018/4885MAPK1 4402/4885 |
| US-20150250882-A1 | Fatty Acid Acylated Amino Acids for Growth Hormone Delivery | GHRHR, GHSR, GHITM | FAAH 53/4885MEN1 2160/4885MAPK1 3488/4885 |
| US-20220411425-A1 | COMPOUNDS USEFUL IN HIV THERAPY | CCR5, CD4, NFATC1 | FAAH 4356/4885MEN1 4273/4885MAPK1 3870/4885 |
| US-20230374045-A1 | AROMATIC BORON-CONTAINING COMPOUNDS AND RELATED INSULIN ANALOGS | IAPP, GPR119, INSR | FAAH 4658/4885MEN1 567/4885MAPK1 997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.